SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment

Detalhes bibliográficos
Autor(a) principal: Noronha, M.
Data de Publicação: 2017
Outros Autores: Moura-Coelho, N., Gomes, T., Flores, R., Medeiros, M.D.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.3980/j.issn.1672-5123.2017.3.3
Resumo: AIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press.
id RCAP_3a8171167512660acac59253868d4434
oai_identifier_str oai:run.unl.pt:10362/24604
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatmentAge-related macular degenerationEllipsoid zoneExternal limiting membraneOptical coherence tomographyVisual acuitybevacizumabage related macular degenerationagedArticlecentral corneal thicknessellipsoid zoneexternal limiting membranefemalefollow uphumanmajor clinical studymaleretina detachmentretina fovearetrospective studyspectral domain optical coherence tomographysubretinal neovascularizationvisual acuityvisual system parametersAIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNNoronha, M.Moura-Coelho, N.Gomes, T.Flores, R.Medeiros, M.D.2017-10-25T22:00:12Z2017-03-082017-03-08T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article5application/pdfhttps://doi.org/10.3980/j.issn.1672-5123.2017.3.3eng1672-5123PURE: 3226889https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014812834&doi=10.3980%2fj.issn.1672-5123.2017.3.3&partnerID=40&md5=3086a343069a5611c267827e40d51276https://doi.org/10.3980/j.issn.1672-5123.2017.3.3info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:12:44Zoai:run.unl.pt:10362/24604Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:28:04.696473Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
title SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
spellingShingle SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
Noronha, M.
Age-related macular degeneration
Ellipsoid zone
External limiting membrane
Optical coherence tomography
Visual acuity
bevacizumab
age related macular degeneration
aged
Article
central corneal thickness
ellipsoid zone
external limiting membrane
female
follow up
human
major clinical study
male
retina detachment
retina fovea
retrospective study
spectral domain optical coherence tomography
subretinal neovascularization
visual acuity
visual system parameters
title_short SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
title_full SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
title_fullStr SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
title_full_unstemmed SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
title_sort SD-OCT morphological changes in wet age-related macular degeneration patients after bevacizumab treatment
author Noronha, M.
author_facet Noronha, M.
Moura-Coelho, N.
Gomes, T.
Flores, R.
Medeiros, M.D.
author_role author
author2 Moura-Coelho, N.
Gomes, T.
Flores, R.
Medeiros, M.D.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Noronha, M.
Moura-Coelho, N.
Gomes, T.
Flores, R.
Medeiros, M.D.
dc.subject.por.fl_str_mv Age-related macular degeneration
Ellipsoid zone
External limiting membrane
Optical coherence tomography
Visual acuity
bevacizumab
age related macular degeneration
aged
Article
central corneal thickness
ellipsoid zone
external limiting membrane
female
follow up
human
major clinical study
male
retina detachment
retina fovea
retrospective study
spectral domain optical coherence tomography
subretinal neovascularization
visual acuity
visual system parameters
topic Age-related macular degeneration
Ellipsoid zone
External limiting membrane
Optical coherence tomography
Visual acuity
bevacizumab
age related macular degeneration
aged
Article
central corneal thickness
ellipsoid zone
external limiting membrane
female
follow up
human
major clinical study
male
retina detachment
retina fovea
retrospective study
spectral domain optical coherence tomography
subretinal neovascularization
visual acuity
visual system parameters
description AIM: To investigate the changes in spectral domain optical coherence tomography (SD-OCT) quantitative and qualitative parameters in a group of patients with age-related macular degeneration (AMD) that underwent bevacizumab intravitreal injections (IV). We assessed if one or more of these parameters can be used as prognostic factors of the post treatment visual acuity (VA). METHODS: Totally 66 eyes of 61 patients, with treatment naive AMD, that were treated with at least 3 monthly bevacizumab IV, were retrospectively studied. SD-OCT quantitative [central foveal thickness (CFT), external limiting membrane (ELM) and ellipsoid zone (EZ) lengths] and qualitative parameters were studied and compared before and after IV. We also tried to establish correlation between these parameters and before/after treatment VA. RESULTS: Mean VA (logMAR), CFT (μm), ELM length(μm) and EZ length (μm) changed from pre-IV values of 0.62±0.41, 419.3±110.0, 378.2±377.2 and 156.4±253.7 to post-IV values of 0.53±0.44, 325.8±117.9, 547.1±421.5 and 173.1±207.1. There was correlation between pre-IV VA and pre-IV CFT (rs=0.27), ELM length (rs=-0.30) and ELM disruption (rs=0.43). There was also correlation between post-IV VA and post-IV ELM length (rs=-0.40). Post-IV VA showed correlation with pre-IV VA (rs=0.66), ELM length (rs=-0.35) and ELM disruption (rs=0.46). CONCLUSION: In our study group pre-IV VA, ELM length and ELM disruption can be used as post-IV VA prognostic factors. Copyright 2017 by the IJO Press.
publishDate 2017
dc.date.none.fl_str_mv 2017-10-25T22:00:12Z
2017-03-08
2017-03-08T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.3980/j.issn.1672-5123.2017.3.3
url https://doi.org/10.3980/j.issn.1672-5123.2017.3.3
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1672-5123
PURE: 3226889
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014812834&doi=10.3980%2fj.issn.1672-5123.2017.3.3&partnerID=40&md5=3086a343069a5611c267827e40d51276
https://doi.org/10.3980/j.issn.1672-5123.2017.3.3
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 5
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137907262357504